NASDAQ:CRBP
$8.05
(
8.05%
)
Wednesday, 29th Mar 2023
Corbus Pharmaceuticals Holdings Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $2.11 | $8.26 | Wednesday, 29th Mar 2023 CRBP stock ended at $8.05. This is 8.05% more than the trading day before Tuesday, 28th Mar 2023. During the day the stock fluctuated 9.84% from a day low at $7.52 to a day high of $8.26. |
| 90 days | $2.11 | $8.26 | |
| 52 weeks | $2.11 | $17.07 |
Historical Corbus Pharmaceuticals Holdings prices
| Date | Open | High | Low | Close | Volume |
| 2023-03-29 | $7.63 | $8.26 | $7.52 | $8.05 | 368 013 |
| 2023-03-28 | $6.69 | $7.58 | $6.66 | $7.45 | 364 179 |
| 2023-03-27 | $6.97 | $7.09 | $6.58 | $6.82 | 120 869 |
| 2023-03-24 | $6.38 | $7.14 | $6.29 | $6.85 | 155 515 |
| 2023-03-23 | $6.64 | $7.01 | $6.26 | $6.46 | 133 624 |
| 2023-03-22 | $6.32 | $6.95 | $6.06 | $6.66 | 233 968 |
| 2023-03-21 | $7.49 | $8.10 | $6.30 | $6.39 | 896 606 |
| 2023-03-20 | $5.67 | $7.17 | $5.65 | $6.91 | 1 421 077 |
| 2023-03-17 | $6.24 | $7.65 | $5.08 | $6.20 | 10 872 957 |
| 2023-03-16 | $2.83 | $5.78 | $2.80 | $5.75 | 7 925 819 |
| 2023-03-15 | $3.00 | $3.11 | $2.76 | $2.91 | 170 264 |
| 2023-03-14 | $2.35 | $3.13 | $2.25 | $3.07 | 564 375 |
| 2023-03-13 | $2.13 | $2.35 | $2.13 | $2.25 | 37 720 |
| 2023-03-10 | $2.38 | $2.39 | $2.11 | $2.14 | 44 904 |
| 2023-03-09 | $2.47 | $2.55 | $2.26 | $2.36 | 60 211 |
| 2023-03-08 | $2.81 | $2.81 | $2.48 | $2.52 | 55 564 |
| 2023-03-07 | $2.87 | $2.94 | $2.66 | $2.66 | 78 259 |
| 2023-03-06 | $2.92 | $3.02 | $2.78 | $2.85 | 77 156 |
| 2023-03-03 | $2.92 | $3.05 | $2.83 | $2.92 | 45 506 |
| 2023-03-02 | $2.87 | $3.10 | $2.76 | $2.95 | 117 546 |
| 2023-03-01 | $2.99 | $3.01 | $2.80 | $2.80 | 45 954 |
| 2023-02-28 | $2.93 | $3.06 | $2.90 | $2.99 | 48 194 |
| 2023-02-27 | $2.80 | $3.03 | $2.77 | $2.96 | 85 124 |
| 2023-02-24 | $2.80 | $2.80 | $2.67 | $2.80 | 30 619 |
| 2023-02-23 | $2.84 | $2.87 | $2.62 | $2.80 | 54 705 |
| 2023-02-22 | $2.85 | $2.91 | $2.76 | $2.79 | 61 375 |
| 2023-02-21 | $3.06 | $3.06 | $2.77 | $2.77 | 132 351 |
| 2023-02-17 | $3.20 | $3.23 | $3.00 | $3.06 | 183 304 |
| 2023-02-16 | $3.08 | $3.47 | $3.01 | $3.20 | 190 956 |
| 2023-02-15 | $3.32 | $3.55 | $3.01 | $3.08 | 214 412 |
| 2023-02-14 | $3.72 | $4.02 | $3.11 | $3.28 | 373 112 |
| 2023-02-13 | $4.94 | $4.99 | $3.90 | $4.27 | 79 880 |
| 2023-02-10 | $5.06 | $5.10 | $4.63 | $4.80 | 30 636 |
| 2023-02-09 | $5.17 | $5.17 | $4.86 | $5.03 | 21 865 |
| 2023-02-08 | $5.07 | $5.19 | $4.86 | $5.16 | 24 507 |
| 2023-02-07 | $5.18 | $5.31 | $4.50 | $4.93 | 83 157 |
| 2023-02-06 | $5.67 | $5.67 | $5.16 | $5.18 | 42 883 |
| 2023-02-03 | $5.25 | $5.64 | $5.14 | $5.15 | 65 019 |
| 2023-02-02 | $5.10 | $5.67 | $5.10 | $5.24 | 225 942 |
| 2023-02-01 | $4.80 | $4.95 | $4.67 | $4.92 | 50 038 |
| 2023-01-31 | $4.55 | $4.80 | $4.50 | $4.65 | 47 632 |
| 2023-01-30 | $4.41 | $4.50 | $4.21 | $4.50 | 33 603 |
| 2023-01-27 | $4.20 | $4.50 | $4.15 | $4.34 | 45 384 |
| 2023-01-26 | $4.41 | $4.41 | $4.11 | $4.20 | 30 189 |
| 2023-01-25 | $4.41 | $4.46 | $4.06 | $4.13 | 24 902 |
| 2023-01-24 | $4.23 | $4.28 | $4.08 | $4.20 | 27 591 |
| 2023-01-23 | $4.35 | $4.35 | $4.05 | $4.20 | 34 931 |
| 2023-01-20 | $4.20 | $4.35 | $4.05 | $4.20 | 30 922 |
| 2023-01-19 | $4.15 | $4.34 | $3.99 | $4.20 | 33 859 |
| 2023-01-18 | $4.50 | $4.50 | $4.05 | $4.14 | 47 890 |
About Corbus Pharmaceuticals Holdings
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibody (mAb) for the treatment of cancer and fibrosis that inhibits the act... CRBP Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
